Olmesartan Shortage Update: What Patients Need to Know in 2026

If you take olmesartan (Benicar) for high blood pressure and you've recently struggled to find it in stock, you may be wondering: is there a shortage? Here's an honest, up-to-date answer — and what you should do to protect your blood pressure management.

Is Olmesartan in Shortage in 2026?

As of 2026, olmesartan (generic) is NOT listed on the FDA's official drug shortage database. This is good news. Unlike some other ARBs that have faced formal shortages, the olmesartan supply chain has remained relatively stable. Generic olmesartan is manufactured by multiple pharmaceutical companies, which generally ensures sufficient overall supply.

However — and this is important — no national shortage does not mean every individual pharmacy will always have it on the shelf. Patients regularly report stock gaps at their local pharmacy, particularly for:

The 5 mg dose (less commonly stocked at chain pharmacies)

Combination products: Benicar HCT (olmesartan + hydrochlorothiazide), Azor (olmesartan + amlodipine), and Tribenzor (olmesartan + amlodipine + HCTZ)

Small independent pharmacies with limited purchasing power

A Brief History: Did Olmesartan Ever Face a Shortage?

Olmesartan has not had a significant national shortage in recent history. However, it was indirectly affected by events in the ARB drug class:

2018: The FDA discovered nitrosamine contamination (NDMA) in valsartan API from certain Chinese manufacturers. This triggered massive recalls across valsartan, losartan, and irbesartan products — not olmesartan itself.

2018-2020: As patients and prescribers scrambled to find alternatives, some shifted to olmesartan, causing temporary demand spikes.

2021-2026: The overall ARB supply chain has stabilized. Olmesartan is generally available, though localized stockouts at specific pharmacies continue to occur.

Why Does My Pharmacy Keep Running Out?

Even without an official shortage, individual pharmacies may run out because:

Their wholesaler temporarily ran low between shipments

A manufacturer ran into temporary production or quality delays

The specific strength you need isn't routinely carried by that pharmacy

High-volume prescribing in your local area depleted supply temporarily

What Should Patients Do Right Now?

Don't panic. Olmesartan is not in a national shortage. Your medication is available — you may just need to find the right pharmacy.

Use medfinder. medfinder calls pharmacies near you to identify which ones have your specific medication and dose in stock — and texts you the results.

Refill early. Request your refill 7-10 days before you run out, not on the last day.

Consider mail-order. A 90-day supply from your insurance's mail-order pharmacy dramatically reduces the risk of running out.

Talk to your doctor. If you truly cannot find olmesartan, your doctor can prescribe a suitable alternative ARB.

The Bottom Line for 2026

Olmesartan is not in a declared shortage in 2026. The medication is generally available, but localized stockouts at specific pharmacies — particularly for the 5 mg dose and combination products — do occur. Proactive refilling, flexibility about which pharmacy you use, and having a backup plan with your doctor are the best defenses against running out.